Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Bioprinting "Track B"

Luiz Bertassoni's Biography



Luiz Bertassoni, Assistant Professor, Oregon Health & Sciences University

Dr. Luiz E. Bertassoni obtained a PhD in Biomaterials and Bioengineering from University of Sydney, and two postdoctoral degrees from University of California San Francisco, and the Harvard-MIT Division of Health Sciences and Technology. Currently, Dr. Bertassoni is an Assistant Professor at Oregon Health and Science University in Portland, OR. He holds appointments in the School of Dentistry, the OHSU Center for Regenerative Medicine and Department of Biomedical Engineering. Luiz leads a multidisciplinary research group working on various aspects of biomaterials and tissue engineering. His work on bioprinting of vascularizes tissues has received extensive attention in the popular media, including Fox News, BBC, The Guardian, Fox Business, Wired.com, Tech Crunch, etc; and was selected as one of the top 100 science stories of 2014 (#64) by Discover Magazine. Luiz is a recipient of over 25 national and international research awards, and serves as an ad-hoc reviewer or editorial board member for over 45 journals in dentistry, biomaterials and bioengineering. Dr. Bertassoni's research studies the use micro-scale technologies and bioprinting for tissue engineering; nanoscale structural and mechanical properties of mineralized tissues; and different aspects of ‘organs-on-a-chip’.

Luiz Bertassoni Image

Luncheon Presentation: 3D Stereolitography Bioprinting of Cell-Laden Hydrogel Microarrays and LEGO-like Modular Bioceramics for Tissue Engineering

Thursday, 4 October 2018 at 12:45

Add to Calendar ▼2018-10-04 12:45:002018-10-04 13:45:00Europe/LondonLuncheon Presentation: 3D Stereolitography Bioprinting of Cell-Laden Hydrogel Microarrays and LEGO-like Modular Bioceramics for Tissue EngineeringSELECTBIOenquiries@selectbiosciences.com

Fabrication of three-dimensional tissues with controlled microarchitectures has been shown to enhance tissue functionality. 3D printing can be used to precisely position cells and cell-laden materials to generate controlled tissue architectures. Therefore, it represents an exciting alternative for organ fabrication. Our group has been interested in developing innovative printing-based technologies to improve our ability to regenerate tissues with improved function, as well as to engineer hydrogel based microfluidic devices. In this seminar, we will present SLA/DLP-based 3D printing methods to fabricate high-throughput screening platforms to probe mechanotransduction and geometry-controlled mechanisms of stem cell differentiation. Further, we will discuss recent methods our lab has developed to engineer hard tissues using stereolitography printing of high-density bioceramics that can be stacked with multiple 3D geometries and improved regenerative capacity.


Add to Calendar ▼2018-10-04 00:00:002018-10-05 00:00:00Europe/London3D-Bioprinting "Track B"SELECTBIOenquiries@selectbiosciences.com